[1] LI L,LIU Y,WU P,et al.Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study[J].Lancet Public Health,2019,4(9):e473-e481. [2] ORTIZ J R,PERUT M,DUMOLARD L,et al.A global review of national influenza immunization policies:analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization[J].Vaccine,2016,34(45): 5400-5405. [3] 中国疾控中心发布《中国流感疫苗预防接种技术指南(2019—2020)》[J].疾病监测,2019,34(10):943. [4] ORTIZ J R,HOMBACH J.Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines[J].Vaccine,2018,36(37):5504-5505. [5] YE C,ZHU W,YU J,et al.Low coverage rate and awareness of influenza vaccine among older people in Shanghai, China:a cross-sectional study[J].Hum Vaccin Immunother,2018,14(11):2715-2721. [6] 孙振球,徐勇勇.医学统计学(第四版)[M].高等教育出版社, 2014. [7] 张惺惺,吴双胜,王全意,等. 北京市2017—2018流行季流感感染率和发病率研究[J].国际病毒学杂志,2019,26(2):73-76. [8] 杨桂月,潘兴强,赵芬,等.中国老年人群流行性感冒疫苗保护效果的Meta分析[J].预防医学,2017,29(6):555-561. [9] 中华人民共和国卫生部.流行性感冒诊断标准:WS 285—2008 [S].北京:人民卫生出版社,2008. [10] 中华人民共和国国家卫生和计划生育委员会.预防接种工作规范(2016版)[S].2017. [11] 常利民,刘大卫,王华庆.国内外疑似预防接种异常反应监测报告和诊断标准的研究现状[J].中国疫苗和免疫,2012, 18(5): 465-468. [12] 占伟海,毛建英,高基民.景宁畲族自治县2~5岁儿童五种疫苗免疫效果分析[J]. 预防医学,2017,29(4):411-413. [13] 赵晋芳,罗天娥, 刘桂芬. 分类重复测量数据的非线性混合效应模型[J]. 现代预防医学, 2007,34(20):3866-3868. [14] CHEN Q,MAY R C,IBRAHIM J G,et al.Joint modeling of longitudinal and survival data with missing and left-censored time-varying covariates[J].Stat Med,2014,33(26):4560-4576. [15] 颜玉炳,蒋丽娜,刘红莲,等.流感样病例中流感病毒阳性检出率的相关因素分析[J]. 中华疾病控制杂志,2015,19(3): 310-312. [16] DEMICHELI V,JEFFEROSONT,DI PIETRANTONJ C,et al.Vaccines for preventing influenza in the elderly[J].Cochrane Database Syst Rev,2018,2(2):CD004876. [17] YANG J,JIT M,ZHENG Y,et al. The impact of influenza on the health related quality of life in China:an EQ-5D survey[J/OL]. BMC Infect Dis,2017[2020-06-12].https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-017-2801-2. |